To maintain microvascular integrity and lessen ischemia injury, these findings collectively emphasize ECM remodeling as a key mechanism in stroke biology, pointing to possible therapeutic targets in MMP inhibition, pericyte stabilization, and TGF-β signaling modulation. The gene discussed is TGFB1; the disease is ischemia.